Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in ACS
NCT00939913Phase 4Unknown
- Sponsor
- Ochsner Clinic Foundation
- Start
- Jan 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Ochsner Clinic Foundation. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00939913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939913.